Since 2016, our company has been utilized by numerous universities, research institutions, and pharmaceutical platforms both domestically and internationally. Our primary business focuses on OEM manufacturing for foreign brands. Although our cumulative number of publications is relatively small, the quality and quantity of our branded publications have consistently increased. This is attributed to our company's investment in product research and development, which has earned widespread recognition for our stable quality among our customers. Currently, we have published over 5,800 articles, with a total impact factor of over 21,000 and a maximum impact factor of 52.7. Over 300 of our publications have an impact factor of 10 or higher, with an average score of 3.77. Our publications have been featured in cutting-edge scientific journals such as Cell Research, Cell, Advanced Materials, Annals of the Rheumatic Diseases, Materials Today, Cellular & Molecular Immunology, and Journal of Medical Virology. Our company is favored and recognized by a wide range of domestic and international users due to our excellent products and comprehensive service system.